Skip to main content
Celon Pharma S.A. logo

Celon Pharma S.A. — Investor Relations & Filings

Ticker · CLN ISIN · PLCLNPH00015 LEI · 259400Q0ERJT0NC5DT24 WAR Manufacturing
Open in API
Filings indexed 709 across all filing types
Latest filing 2022-04-28 Annual Report
Country PL Poland
Listing WAR CLN

About Celon Pharma S.A.

https://celonpharma.com/en/

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Recent filings

Filing Released Lang Actions
Sprawozdanie z działalności Zarządu Celon Pharma SA
Annual Report Classification · 1% confidence The document is titled 'Sprawozdanie Zarządu z działalności Celon Pharma S.A. za rok 2021' (Management Report on the activities of Celon Pharma S.A. for the year 2021). It contains detailed financial data, including balance sheets, income statements, cash flow statements, and management commentary on business performance, strategy, and risks for the full fiscal year 2021. While it is a management report, it serves as the primary comprehensive financial reporting document for the fiscal year, fitting the definition of an Annual Report (10-K) in the context of global corporate filings. FY 2021
2022-04-28 Polish
Sprawozdanie finansowe za rok 2021
Audit Report / Information Classification · 1% confidence The document text explicitly contains titles in Polish such as "SPRAWOZDANIE FINANSOWE ZA ROK ZAKOŃCZONY DNIA 31 GRUDNIA 2021 ROKU" (Financial Statement for the Year Ended December 31, 2021), followed by detailed sections like "Sprawozdanie z całkowitych dochodów" (Statement of Comprehensive Income), "Sprawozdanie z sytuacji finansowej" (Statement of Financial Position/Balance Sheet), and "Sprawozdanie z przepływów pieniężnych" (Cash Flow Statement). It also includes a table comparing results for the years ended December 31, 2021, and December 31, 2020, and mentions an "SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA" (Independent Auditor's Report on the Audit). This structure is characteristic of a comprehensive annual financial report, which corresponds to the 10-K filing type in the US context, or its equivalent for comprehensive annual reporting. FY 2021
2022-04-28 Polish
Sprawozdanie_fin_2022-04-27_pl.xhtml.xades
Audit Report / Information Classification · 1% confidence The document text consists almost entirely of XML digital signature blocks (Signatures, SignedInfo, SignatureValue, KeyInfo, X509Certificate, etc.). One of the references within the signature block points to a URI named "Sprawozdanie_fin_2022-04-27_pl.xhtml". The term 'Sprawozdanie finansowe' translates to 'Financial Report' in Polish. The date associated is April 27, 2022. Since the document provided is the *signature* structure wrapping the financial report (XHTML file), and not the report content itself, and given the document length is substantial (19968 chars), it is most likely an official filing containing the signed report. However, the structure strongly suggests this is the metadata/signature wrapper of a filing, rather than the full content of a standard report like 10-K or IR. The presence of a specific financial report reference ('Sprawozdanie_fin') points towards a formal financial disclosure. Given the options, and the fact that it's a comprehensive financial document (implied by the signature structure and file name), it is most likely an Interim/Quarterly Report (IR) or potentially an Annual Report (10-K) if the date was year-end, but without content context, IR is a safer bet for a comprehensive period report that isn't explicitly the 10-K. Since the document is clearly a signed financial statement wrapper, and not a short announcement, I will classify it as a comprehensive financial report. Given the Polish context and the lack of explicit '10-K' headers, 'IR' (Interim/Quarterly Report) is the best fit for a comprehensive financial statement filing that isn't the annual report. FY 2022
2022-04-28 Polish
CELON_RAPORT_Y2021__2022-04-27_pl.xhtml.xades
Regulatory Filings Classification · 1% confidence The provided document text consists almost entirely of XML structures related to digital signatures (Signature, SignedInfo, DigestValue, X509Certificate, etc.). This structure is characteristic of a digitally signed document, often used for regulatory filings or official reports to ensure authenticity and integrity. Key indicators are: 1. The presence of 'Signature' and 'SignedInfo' blocks. 2. References to specific files being signed, such as 'URI="CELON_RAPORT_Y2021__2022-04-27_pl.xhtml"'. The filename suggests a report ('RAPORT') for the year 2021, dated April 27, 2022. 3. The document length is 10256 characters, which is substantial, suggesting it is not just a brief announcement. 4. The content is the signature block itself, not the narrative content of the report it authenticates. When a document is primarily the digital signature wrapper for a report (like an XHTML file mentioned in the URI), and the actual report content is not present, it is best classified as a general Regulatory Filing (RNS) or, if the context strongly implies a specific report type is attached/referenced, we might lean towards that. However, since the text *is* the signature block and not the report content, and the filename suggests a 'RAPORT' (Report), the most accurate classification for the *wrapper* itself, without seeing the content, is often RNS (Regulatory Filings) as a general container for official, signed documents that don't fit other specific categories like 10-K or ER. However, given the filename 'CELON_RAPORT_Y2021__2022-04-27_pl.xhtml', this strongly implies the underlying document is a comprehensive annual or periodic report. Since the text provided is the signature block *for* a report, and the document length is significant (ruling out RPA based on the 'Menu vs Meal' rule if we assume the signature block is just metadata for the main report), we must decide if this signature block *is* the filing or if it *contains* the filing. In many SEC/global filing systems, the signed wrapper is submitted alongside the content. Given the lack of narrative content and the focus on the signature, RNS is the safest general classification for the wrapper itself. If we assume this signature block is attached to a full annual report (Y2021), 10-K might be considered, but the text itself is not the 10-K. Given the ambiguity and the nature of the content (a digital signature wrapper), RNS (Regulatory Filings) is the most appropriate fallback for a document that is clearly official but whose primary content is technical metadata (the signature) rather than the financial narrative itself.
2022-04-28 Polish
List do Akcjonariuszy
Management Reports Classification · 1% confidence The document is a letter from the CEO (Maciej Wieczorek) to shareholders, summarizing the company's activities, strategic goals, and business outlook for the year 2021. It does not contain the full financial statements or the comprehensive audit required for a 10-K or an Interim Report. Instead, it functions as a management commentary or a narrative overview of the company's performance and future direction. Given the structure and content, it aligns best with the Management Reports (MDA) category, which covers management's detailed explanation of business trends and outlook. FY 2021
2022-04-28 Polish
Oświadczenie Rady Nadzorczej Celon Pharma S.A.dotyczące wyboru firmy audytorskiej
Audit Report / Information Classification · 1% confidence The document text is a formal declaration ('Oświadczenie') from the Supervisory Board ('Rada Nadzorcza') of Celon Pharma S.A. regarding the selection of the auditing firm ('firma audytorska') for the 2021 financial statement audit. It confirms compliance with regulations regarding impartiality, independence, rotation, and related service policies. This content directly relates to the formal process and results of an audit engagement, fitting the description of an Audit Report / Information document, which covers applied accounting principles and results of internal/regulatory checks related to auditing, even if it's a statement *about* the auditor rather than the full audit report itself. Given the specific focus on the auditor's selection and compliance, 'AR' (Audit Report / Information) is the most appropriate classification, as it deals with the integrity and process surrounding the financial audit. FY 2021
2022-04-28 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.